Achilles Therapeutics Stock Forecast - Naive Prediction

ACHLDelisted Stock  USD 1.48  0.00  0.00%   
The Naive Prediction forecasted value of Achilles Therapeutics PLC on the next trading day is expected to be 1.62 with a mean absolute deviation of 0.03 and the sum of the absolute errors of 2.04. Achilles Stock Forecast is based on your current time horizon.
As of now the value of rsi of Achilles Therapeutics' share price is below 20 . This suggests that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards.

Momentum 0

 Sell Peaked

 
Oversold
 
Overbought
The successful prediction of Achilles Therapeutics' future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Achilles Therapeutics and does not consider all of the tangible or intangible factors available from Achilles Therapeutics' fundamental data. We analyze noise-free headlines and recent hype associated with Achilles Therapeutics PLC, which may create opportunities for some arbitrage if properly timed.
Using Achilles Therapeutics hype-based prediction, you can estimate the value of Achilles Therapeutics PLC from the perspective of Achilles Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
The Naive Prediction forecasted value of Achilles Therapeutics PLC on the next trading day is expected to be 1.62 with a mean absolute deviation of 0.03 and the sum of the absolute errors of 2.04.

Achilles Therapeutics after-hype prediction price

    
  USD 1.48  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as delisted stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.

Achilles Therapeutics Additional Predictive Modules

Most predictive techniques to examine Achilles price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Achilles using various technical indicators. When you analyze Achilles charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
A naive forecasting model for Achilles Therapeutics is a special case of the moving average forecasting where the number of periods used for smoothing is one. Therefore, the forecast of Achilles Therapeutics PLC value for a given trading day is simply the observed value for the previous period. Due to the simplistic nature of the naive forecasting model, it can only be used to forecast up to one period.

Achilles Therapeutics Naive Prediction Price Forecast For the 13th of January 2026

Given 90 days horizon, the Naive Prediction forecasted value of Achilles Therapeutics PLC on the next trading day is expected to be 1.62 with a mean absolute deviation of 0.03, mean absolute percentage error of 0, and the sum of the absolute errors of 2.04.
Please note that although there have been many attempts to predict Achilles Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Achilles Therapeutics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

Achilles Therapeutics Stock Forecast Pattern

Backtest Achilles TherapeuticsAchilles Therapeutics Price PredictionBuy or Sell Advice 

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Achilles Therapeutics stock data series using in forecasting. Note that when a statistical model is used to represent Achilles Therapeutics stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information Criteria111.9196
BiasArithmetic mean of the errors None
MADMean absolute deviation0.0334
MAPEMean absolute percentage error0.0264
SAESum of the absolute errors2.0371
This model is not at all useful as a medium-long range forecasting tool of Achilles Therapeutics PLC. This model is simplistic and is included partly for completeness and partly because of its simplicity. It is unlikely that you'll want to use this model directly to predict Achilles Therapeutics. Instead, consider using either the moving average model or the more general weighted moving average model with a higher (i.e., greater than 1) number of periods, and possibly a different set of weights.

Predictive Modules for Achilles Therapeutics

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Achilles Therapeutics PLC. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
1.481.481.48
Details
Intrinsic
Valuation
LowRealHigh
1.151.151.63
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Achilles Therapeutics. Your research has to be compared to or analyzed against Achilles Therapeutics' peers to derive any actionable benefits. When done correctly, Achilles Therapeutics' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Achilles Therapeutics PLC.

Achilles Therapeutics Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Achilles Therapeutics stock to make a market-neutral strategy. Peer analysis of Achilles Therapeutics could also be used in its relative valuation, which is a method of valuing Achilles Therapeutics by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Achilles Therapeutics Market Strength Events

Market strength indicators help investors to evaluate how Achilles Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Achilles Therapeutics shares will generate the highest return on investment. By undertsting and applying Achilles Therapeutics stock market strength indicators, traders can identify Achilles Therapeutics PLC entry and exit signals to maximize returns.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Prophet
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.
You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.

Other Consideration for investing in Achilles Stock

If you are still planning to invest in Achilles Therapeutics PLC check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Achilles Therapeutics' history and understand the potential risks before investing.
Fundamental Analysis
View fundamental data based on most recent published financial statements
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk